Oral Session 3-13B MPN: Clinical (Prognosis)

[OS3-13B-2] Transformation to acute leukemia in myeloproliferative neoplasms with IDH mutations

Motoyuki Kawano¹, Kotaro Shide², Ayako Kamiunten², Yoko Kubuki², Masami Takeuchi³, Kosei Matsue³, Noriaki Kawano⁴, Kiyoshi Yamashita⁴, Osamu Imataki⁵, Norimitsu Kadowaki⁵, Kentaro Fukushima⁶, Takahiro Karasuno⁶, Taizo Shimomura⁷, Hitoshi Suzushima⁷, Akihito Yonezawa⁸, Eiichi Otsuka⁹, Yoshio Saburi⁹, Tomonori Hidaka², Takuro Kameda², Keiichi Akizuki², Masaaki Sekine², Yuki Tahira², Kazuya Shimoda² (1.Clinical Training Center after Graduation, University of Miyazaki, Miyazaki, Japan, 2.Department of Hematology, University of Miyazaki, Miyazaki, Japan, 3.Kameda Medical Center, Kamogawa, Japan, 4.Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan, 5.Faculty of Medicine, Kagawa University, Kagawa, Japan, 6.Rinku General Medical Center, Izumisano, Japan, 7.Shinto General Hospital, Kumamoto, Japan, 8.Kokura Memorial Hospital, Kitakyushu, Japan, 9.Oita Prefectural Hospital, Oita, Japan)